Mount Sinai Health System
Mount Sinai Health System is an integrated healthcare system based in New York, providing exceptional medical care to local and global communities. Established in 2013 through the merger of Mount Sinai Medical Center and Continuum Health Partners, it encompasses the Icahn School of Medicine and operates seven hospital campuses throughout the New York metropolitan area. The system is recognized for its excellence in research, patient care, and education across various specialties. It features a vast network of over 7,000 primary and specialty care physicians, as well as more than 45 ambulatory practices and 12 minority-owned free-standing ambulatory surgery centers. Mount Sinai is committed to improving healthcare quality and accessibility, focusing on compassionate patient experiences and the development of strong relationships between staff and patients. Additionally, its venture capital arm, Mount Sinai Ventures, invests in healthcare startups, further enhancing its capacity to innovate and respond to the diverse health needs of the populations it serves.
https://crunchbase.com/organization/***
https://linkedin.com/company/***
4 past transactions
PreciseDx
Series A in 2022
PreciseDx is a specialized company focused on cancer risk stratification, providing patient-specific risk assessments through the analysis of morphological features. By leveraging artificial intelligence and its proprietary Morphology Feature Array™, PreciseDx develops disease-specific assays that enhance the understanding of a patient's risk profile and potential outcomes. This innovative approach allows clinical teams to gain valuable insights and actionable intelligence, facilitating more personalized treatment decisions. The company's expertise spans clinical modeling, patient phenotyping, image analysis, and the application of big data in real-world scenarios, ultimately aiming to improve patient outcomes and quality of life in cancer care and other diseases.
Deliberate AI
Grant in 2020
Deliberate AI specializes in multimodal artificial intelligence solutions aimed at enhancing mental health clinical trials and healthcare applications. The company focuses on three core areas: advanced diagnostics and monitoring, precision therapy enablement, and ambient clinical intelligence. By utilizing AI-based algorithms, Deliberate AI provides regulatory-grade objective measurement technology tailored for behavioral and mental health care. This platform equips clinicians, physicians, and healthcare researchers with critical data insights, enabling effective diagnostics and continuous monitoring for mental and neurological health challenges. Through its innovative approach, Deliberate AI aims to improve the quality of care and outcomes in mental health and clinical research.
Trellus Health
Seed Round in 2020
Trellus Health Inc. is a digital health company that specializes in providing resilience-driven solutions for chronic gastrointestinal conditions, particularly inflammatory bowel disease and irritable bowel syndrome. Founded in 2020 and headquartered in White Plains, New York, with an additional office in Cardiff, United Kingdom, Trellus Health offers a telehealth-based, multidisciplinary clinic that coordinates access to high-quality clinical care. Its connected care platform delivers whole-person care, integrating clinical and behavioral health services to enhance patient outcomes and reduce healthcare costs. The company's evidence-based management program incorporates a resilience-based behavior change approach, live one-on-one coaching, and user-friendly applications designed to improve overall resilience, promote better self-management, and support mental health for individuals facing these chronic conditions.
Gauss Surgical
Series C in 2018
Gauss Surgical, Inc. is a medical technology company that specializes in real-time blood monitoring solutions to enhance patient outcomes in surgical and obstetric settings. Founded in 2011 and headquartered in Los Altos, California, Gauss Surgical develops the Triton system, which includes various models suited for different medical needs. Triton assists healthcare professionals in monitoring and estimating blood loss during procedures, allowing for timely intervention in cases of hemorrhage. The system offers objective metrics for blood loss, thereby facilitating better clinical decision-making regarding transfusions. Serving the healthcare sector primarily in the United States, Gauss Surgical's products are designed to integrate seamlessly into existing medical practices, using sophisticated algorithms and HIPAA-compliant technology to deliver accurate monitoring in real time.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.